Clinical Trials Directory

Trials / Terminated

TerminatedNCT03111758

Flow Augmentation Study in Postthrombotic Patients

Flow Augmentation With Geko Device in Patients With Postthrombotic Syndrome a Prospective Randomised Cross-Over Trial

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
10 (actual)
Sponsor
Maastricht University Medical Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Rationale: Stent therapy has been proven to be an effective form of therapy in the treatment of chronic iliofemoral and iliocaval post-thrombotic obstruction. During the first post-intervention day intermittent pneumatic compression stockings (IPCS) are necessary to augment venous flow. This will inherently prevent early stent occlusion. Our aim is to investigate whether the Geko device is effective as IPCS regarding augmentation of flow in post-thrombotic patients during the first day after stenting. Objective: The primary objective of this study is to identify whether the Geko system is effective in augmenting flow compared to IPCS in post-thrombotic limbs before after stenting. Study design: Interventional pilot study with randomized cross-sectional design. Study population: Patients with a post-thrombotic obstruction undergoing a percutaneous procedure (PTA, stenting). Intervention (if applicable): Treatment with intermittent pneumatic compression stockings (IPCS) and Geko-device. Main study parameters/endpoints: The main endpoint and parameter of this study is time-averaged maximum flow velocity (TAMFV), measured by duplex ultrasonography using its pulse wave Doppler function.

Conditions

Interventions

TypeNameDescription
DEVICEFlow augmentationAugmenting venous flow following deep venous stenting in patients with Postthrombotic syndrome

Timeline

Start date
2017-04-03
Primary completion
2021-08-05
Completion
2021-08-05
First posted
2017-04-13
Last updated
2022-03-04

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT03111758. Inclusion in this directory is not an endorsement.